The acquisition will add UBC’s suite of electronic data capture (EDC), interactive voice response (IVRS) and drug and medical device safety testing technologies to Medco’s Existing pharmacy services offering.
“The acquisition of UBC represents Medco’s ongoing commitment to provide innovation and value in healthcare, extending our global footprint into the areas of health information technology, information services and research,” says David Snow Jr, Medco CEO.
“UBC’s products and services broaden the Medco portfolio consistent with our core mission of making medicine smarter through the generation, translation and application of evidence critical to the delivery of high-quality, cost-efficient care that improves patient outcomes.”
The companies say UBS will report approximately $280m in revenue this year, and under the new agreement, due to close in the third quarter, Medco expect shareholders to see a slight profit during 2011.